🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Placebo Controlled, double-blind randomized controlled trial (RCT) with 12 ...
Status
Completed
Location
University of Alberta
Start Date
2021-03-01
Trial ID
NCT03954327
Treatments Being Tested
Primary biliary cirrhosis (PBC) is a chronic cholestatic liver disease that...
Status
Completed
Location
Hepatology department - Hopital Saint Antoine
Start Date
2012-10-15
Trial ID
NCT01654731
Treatments Being Tested
Current treatment guidelines recommend ursodeoxycholic acid (UDCA) as the f...
Status
Recruiting
Location
The second hospital of Lanzhou University
Start Date
2023-02-22
Trial ID
NCT05751967
Treatments Being Tested
The safety and efficacy of probiotics in primary biliary cholangitis (PBC) ...
Status
Unknown
Location
Third Affliated Hospital of Sun Yat-sen University
Start Date
2020-01-20
Trial ID
NCT03521297
The purpose of this study is to determine the safety, tolerability, and act...
Status
Completed
Location
NGM Clinical Study Site 103
Start Date
2014-02
Trial ID
NCT02026401
This is a Phase III, randomized, double-blind, multicentre study assessing ...
Status
Completed
Location
The First Hospital of Jilin University
Start Date
2021-10-09
Trial ID
NCT06715319
The study is aimed to compare the efficacy and tolerability of a combinatio...
Status
Terminated
Location
Hôpital Saint-Antoine
Start Date
2009-02
Trial ID
NCT00746486
Treatments Being Tested
The study is a randomized, double-blind, placebo-controlled, multicenter st...
Status
Completed
Location
Scripps Clinic
Start Date
2013-08
Trial ID
NCT01904058
Treatments Being Tested
The main objectives of the study were to assess the effects of fenofibrate ...
Status
Active Not Recruiting
Location
The second hospital of Lanzhou University
Start Date
2023-08-21
Trial ID
NCT06174402
Treatments Being Tested
The primary hypothesis is that INT-747 will cause a reduction in alkaline p...
Status
Terminated
Location
U Florida Hepatology
Start Date
2007-10
Trial ID
NCT00550862
Treatments Being Tested